Search results for "IRON-DEFICIENCY"

showing 10 items of 36 documents

Changes in myocardial iron content following administration of intravenous iron (Myocardial‐IRON): Study design

2018

Treatment with intravenous ferric carboxymaltose (FCM) has been shown to improve symptoms, functional capacity, and quality of life in patients with heart failure and iron deficiency. However, the underlying mechanisms for these beneficial effects remain undetermined. The aim of this study is to quantify cardiac magnetic resonance changes in myocardial iron content after administration of intravenous FCM in patients with heart failure and iron deficiency and contrast them with parameters of heart failure severity. This is a multicenter, double-blind, randomized study. Fifty patients with stable symptomatic heart failure, left ventricular ejection fraction <50%, and iron deficiency will be r…

MaleTime FactorsMyocardial ironheart failure030204 cardiovascular system & hematologyFerric CompoundsSeverity of Illness IndexVentricular Function Left030218 nuclear medicine & medical imaginglaw.invention0302 clinical medicineiron deficiencyClinical ProtocolsQuality of lifeRandomized controlled triallawCardiac Magnetic Resonance Ferric Carboxymaltose Heart Failure Iron Deficiency Myocardial IronInfusions IntravenousEjection fractionAnemia Iron-DeficiencyGeneral MedicineIron deficiencyferric carboxymaltoseTreatment OutcomeResearch DesignCardiologyFemaleCardiology and Cardiovascular MedicineCardiac function curvemedicine.medical_specialtyTrial DesignsMagnetic Resonance Imaging CinePlacebocardiac magnetic resonance03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansMaltosemyocardial ironAgedHeart Failurebusiness.industryMyocardiumStroke VolumeRecovery of Functionmedicine.diseaseSpainHeart failureHematinicsQuality of Lifebusiness
researchProduct

Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction.

2015

Malemedicine.medical_specialty030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansIn patient030212 general & internal medicineProspective StudiesProspective cohort studyAgedHeart FailureAnemia Iron-Deficiencybusiness.industryVO2 maxStroke VolumeStroke volumeIron deficiencymedicine.diseaseHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionCohort studyInternational journal of cardiology
researchProduct

Obesity and iron deficiency anemia as risk factors for asymptomatic bacteriuria.

2013

Background: Few studies examined the risk factors of asymptomatic bacteriuria, showing contradictory results. Our study aimed to examine the association between different clinical and laboratory parameters and asymptomatic bacteriuria in internal medicine patients. Materials and methods: 330 consecutive hospitalized subjects, asymptomatic for urinary tract infections (UTIs), underwent to microscopic examination of urine specimens. 100 subjects were positive for microscopic bacteriuria and were recruited into the study. At the quantitative urine culture 31 subjects of study population were positive while 69 subjects were negative for bacteriuria. Results: The analysis of clinical characteris…

Malemedicine.medical_specialtyBacteriuriaAnemiaUrinary systemUrineBacteriuriaurologic and male genital diseasesAsymptomaticRisk FactorsInternal medicineInternal MedicinemedicineHumansObesityAsymptomatic InfectionsAgedAnemia Iron-Deficiencybusiness.industryobesity anemia asymptomatic bacteriuriaOdds ratiobacterial infections and mycosesmedicine.diseasefemale genital diseases and pregnancy complicationsSurgeryIron-deficiency anemiaPopulation studyFemalemedicine.symptombusinessEuropean journal of internal medicine
researchProduct

A New Potential Dietary Approach to Supply Micronutrients to Physically Active People through Consumption of Biofortified Vegetables

2022

Micronutrients are required in many reactions involved in physical activity and exercise. Most physically active people do not meet the body&rsquo;s needs in terms of micronutrients through diet. The novelty of the present manuscript is the use of an innovative dietary approach to supply micronutrients to physically active people through biofortified food. Therefore, the key point of this study was to verify whether supplementation with biofortified vegetables&mdash;and specifically molybdenum (Mo)-enriched lettuce&mdash;in healthy volunteers affects essential regulators of body homeostasis and, specifically, hematological parameters, iron and lipid metabolism, and hepatic function. Twenty-…

MolybdenumNutrition and DieteticsAnemia Iron-DeficiencyIronTransferrinvegetarian dietsDietdietary supplementsmicronutrientsVegetablesHumansiron homeostasisdietary supplements; micronutrients; molybdenum; vegetarian diets; iron homeostasisFood ScienceNutrients
researchProduct

Anaemia in the critically ill patient: monitoring of erythropoietin therapy

2006

Nephrologymedicine.medical_specialtyRemote patient monitoringAnemiaCritical IllnessUrologyTreatment outcomeInternal medicinemedicineHumansErythropoiesisIntensive care medicineErythropoietinAnemia Iron-DeficiencyDose-Response Relationship DrugCritically illbusiness.industrymedicine.diseaseRecombinant ProteinsSurgeryTreatment OutcomeIron-deficiency anemiaErythropoietinErythropoietin therapyHematinicsDrug Monitoringbusinessmedicine.drugBJU International
researchProduct

Extreme thrombocytosis as a sign of coeliac disease in the elderly: case report

2002

Increase in the number of blood platelets to over 1 000 000/mm 3 in elderly patients is generally considered secondary to a myeloproliferative or neoplastic disease. To report the case of an elderly woman hospitalized for extreme thrombocytosis associated with severe anaemia, who was found to be suffering from coeliac disease. The patient, aged 83 years, was hospitalized presenting with fatigue. Laboratory tests showed microcytic hypochromic anaemia (haemoglobin 4 g/dl) and extreme thrombocytosis (platelet count 1 400 000/mm 3 ). Physical examination was normal, with the exception of marked thinness. There was no evidence of macroscopic bleeding from the gastrointestinal or genitourinary tr…

Pathologymedicine.medical_specialtySettore MED/09 - Medicina InternaAtrophic gastritisPhysical examinationRisk AssessmentSeverity of Illness IndexCoeliac diseaseDiagnosis DifferentialHumanscoeliac disease thrombocytosis iron-deficiency anaemia elderlyMedicineIntestinal MucosaAgedAged 80 and overThrombocytosisLamina propriaHepatologymedicine.diagnostic_testThrombocytosisPlatelet Countbusiness.industryGastroenterologyPrognosismedicine.diseaseCeliac Diseasemedicine.anatomical_structureIron-deficiency anemiaSerum ironAbdomenFemalebusinessEuropean Journal of Gastroenterology &amp; Hepatology
researchProduct

756 The Effectiveness of RDW-CV in Differentiating Microcytic Anemia

2012

Backround: Iron deficiency anemia (IDA) and thalassemia are the most common microcytic anemia in children. Sometimes, expensive or invasive investigations are necessary for their distinction. Red cell distribution - coefficient variation (RDW-CV) is a new generation marker more often used in differentiating IDA from thalassemia. A number of hematological indices are also useful (Mentzer, Shine&Lal, Green&King, Ricerca). Aim To demonstrate the effectiveness RDW - CV in differentiating microcytic anemia. Method Retrospective study conducted on a total of 215 patients with microcytic anemia. Criteria for study group selection: MCV and Hb below the minimum age reference (mild anemia, Hb between…

Pediatricsmedicine.medical_specialtyAnemiabusiness.industryMicrocytic anemiaThalassemiaRed blood cell distribution widthRetrospective cohort studymedicine.diseaseIron-deficiency anemiaHematologic disordershemic and lymphatic diseasesPediatrics Perinatology and Child HealthmedicinebusinessPathologicalArchives of Disease in Childhood
researchProduct

An association between plasma ferritin concentrations measured 48 h after delivery and postpartum depression.

2010

Abstract Context Iron deficiency is the most common nutritional problem experienced by childbearing women, and postpartum depression (PPD) is the most common psychiatric disorder seen during the first year after delivery. The possible link between iron deficiency and PPD is not clear. Objective To evaluate whether iron status 48 h after delivery was associated with PPD. Our hypothesis was that iron deficiency would be associated with PPD. Design This was a prospective cohort study of depression-free women studied in the postpartum period. Setting Women who give birth at obstetric units in several general hospitals in Spain. Participants A subsample of 729 women was included in the present s…

Postpartum depressionAdultmedicine.medical_specialtyTime FactorsAnemiaContext (language use)Statistics NonparametricDepression PostpartummedicineHumansProspective Studieschemistry.chemical_classificationPsychiatric Status Rating ScalesChi-Square DistributionbiologyAnemia Iron-DeficiencyTransferrin saturationbusiness.industryObstetricsPostpartum PeriodIron deficiencymedicine.diseaseFerritinPsychiatry and Mental healthClinical PsychologyLogistic ModelschemistryTransferrinSpainImmunologyFerritinsbiology.proteinFemalebusinessPostpartum periodJournal of affective disorders
researchProduct

Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018

2021

Anemia is a globally widespread condition in women and is associated with reduced economic productivity and increased mortality worldwide. Here we map annual 2000–2018 geospatial estimates of anemia prevalence in women of reproductive age (15–49 years) across 82 low- and middle-income countries (LMICs), stratify anemia by severity and aggregate results to policy-relevant administrative and national levels. Additionally, we provide subnational disparity analyses to provide a comprehensive overview of anemia prevalence inequalities within these countries and predict progress toward the World Health Organization’s Global Nutrition Target (WHO GNT) to reduce anemia by half by 2030. Our results …

Psychological interventionDiseasesResearch & Experimental MedicineGlobal HealthPrevalence11 Medical and Health Sciencesmedia_commonCHILD GROWTH FAILUREPublic Health Global Health Social Medicine and EpidemiologyAnemiaGeneral MedicineMiddle AgedanemiaPeer reviewIRON-DEFICIENCYNutritional StatuPREGNANCYMedicine Research & ExperimentalScale (social sciences)reproductive age/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingA990 Medicine and Dentistry not elsewhere classifiedFemalewomenLife Sciences & Biomedicinevulnerable populationsHumanAdultmedicine.medical_specialtyBiochemistry & Molecular BiologyInequalityAdolescentAnemiamedia_common.quotation_subjectMODELSImmunologyNutritional StatusReproductive ageLocal Burden of Disease Anaemia CollaboratorsGeneral Biochemistry Genetics and Molecular BiologyDeveloping CountrieYoung AdultSDG 3 - Good Health and Well-beingEnvironmental healthmedicineLife ScienceHumansDeveloping CountriesPovertyGlobal NutritionPregnancyWereldvoedingScience & Technologybusiness.industryPublic healthCell BiologyGLOBAL BURDENmedicine.diseaseFolkhälsovetenskap global hälsa socialmedicin och epidemiologiRisk factors1182 Biochemistry cell and molecular biology3111 Biomedicinebusiness
researchProduct

Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate

2021

Complex iron nanoparticle-based drugs are one of the oldest and most frequently administered classes of nanomedicines. In the US, there are seven FDA-approved iron nanoparticle reference drug products, of which one also has an approved generic drug product (i.e., sodium ferric gluconate (SFG)). These products are indicated for the treatment of iron deficiency anemia and are administered intravenously. On the molecular level, iron nanomedicines are colloids composed of an iron oxide core with a carbohydrate coating. This formulation makes nanomedicines more complex than conventional small molecule drugs. As such, these products are often referred to as nonbiological complex drugs (e.g., by t…

Quality ControlDrugChemistry Pharmaceuticalmedia_common.quotation_subjectIron oxidePharmaceutical ScienceEquivalence Trials as Topic02 engineering and technologyFerric Compounds030226 pharmacology & pharmacyGel permeation chromatography03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePharmacokineticsDynamic light scatteringGeneric drugDrug DiscoveryDrugs GenericHumansInductively coupled plasma mass spectrometrymedia_commonAnemia Iron-Deficiency021001 nanoscience & nanotechnologySmall moleculeDynamic Light ScatteringchemistryChromatography GelNanoparticlesMolecular Medicine0210 nano-technologyUltracentrifugationNuclear chemistryMolecular Pharmaceutics
researchProduct